New: Video Access to BIO CEO panels and fireside chats available now 

Did you miss the 2018 BIO CEO & Investor Conference, held February 12-13 in New York? Gain access to recorded video of 16 educational sessions, including panel discussions and fireside chats. 

Request your digital package for only $199
June 19-22, 2017 | San Diego, CA
Partnering & Education: Monday - Thursday
Exhibition: Tuesday - Thursday
  • Immuno-Oncology Milestones to Come: Pipelines Beyond CAR-T 1.0
  • The Art of the Exit: Planning for Your Company’s Acquisition
  • Updating Your China Growth Strategy: Opportunities in Investor and Regulatory Dynamism
  • Advances in Dermatology: Recent Approvals and Later-Stage Trials
  • Funding Cures: Prioritizing Policy Barriers to Amortization of Therapeutic Spending
  • Chronic Disease Innovation: Issues and Opportunities in Addressing Unmet Need for Small and Large Companies
  • Market Outlook—How Durable is the IPO Resurgence and M&A Slowdown?
  • Neuroscience of Addiction: Levers to Attack the Opioid Abuse Crisis
  • Policy Outlook—Implications of the Tax Code Changes of the Trump Administration
  • Instilling Innovation Ambitions in your Leadership Culture

Fireside Chats:
  • Deborah Dunsire, MD, President and Chief Executive Officer, XTuit Pharmaceuticals
  • Lan Huang, PhD, Co-Founder, Chairman and Chief Executive Officer, BeyondSpring Pharmaceuticals
  • Jeffrey D. Marrazzo, Co-Founder and Chief Executive Officer, Spark Therapeutics
  • Vivek Ramaswamy, Founder and Chief Executive Officer, Roivant Sciences
  • Vicki Sato, PhD, Chairman, Denali Therapeutics; Chairman, Vir Biotechnology
  • Rachel Sherman, MD, MPH, Principal Deputy Commissioner, U.S. Food and Drug Administration (FDA)
To view the full program, click here.

Please allow two business days for processing.